IP Verse

Inserm Institut National De La Sant Et De La Recherche Mdicale competitive analysis

Latest publications and patents of Inserm Institut National De La Sant Et De La Recherche Mdicale New

Explore the latest publications and patents granted to Inserm Institut National De La Sant Et De La Recherche Mdicale, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Inserm Institut National De La Sant Et De La Recherche Mdicale
EP3911354	Apr 3, 2024	Aav-Mediated Gene Therapy Restoring The Otoferlin Gene	Granted And Under Opposition
EP3066203	Nov 8, 2023	New Alzheimer'S Disease Animal Model	Patent Maintained As Amended
EP3995507	Oct 4, 2023	Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines	Granted And Under Opposition
EP3768304	Oct 12, 2022	Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins	Granted And Under Opposition
EP3059307	May 4, 2022	Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells	Patent Maintained As Amended
EP3320101	Aug 11, 2021	Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject	Granted And Under Opposition
EP3212200	Jan 20, 2021	Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases	Granted And Under Opposition
EP3256573	Dec 9, 2020	Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography	Granted And Under Opposition
EP3256574	Nov 25, 2020	Recombinant Adeno-Associated Virus Particle Purification Comprising An Affinity Purification Step	Granted And Under Opposition
EP3153526	Sep 23, 2020	Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity	Granted And Under Opposition

Latest patents of Inserm Institut National De La Sant Et De La Recherche Mdicale opposed by its competitors

Explore Inserm Institut National De La Sant Et De La Recherche Mdicale's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3911354	Apr 3, 2024	Aav-Mediated Gene Therapy Restoring The Otoferlin Gene	4
EP3066203	Nov 8, 2023	New Alzheimer'S Disease Animal Model	1
EP3995507	Oct 4, 2023	Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines	1
EP3768304	Oct 12, 2022	Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins	6
EP3059307	May 4, 2022	Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells	1
EP3320101	Aug 11, 2021	Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject	1
EP3212200	Jan 20, 2021	Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases	1
EP3256573	Dec 9, 2020	Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography	1
EP3256574	Nov 25, 2020	Recombinant Adeno-Associated Virus Particle Purification Comprising An Affinity Purification Step	7
EP3153526	Sep 23, 2020	Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity	4

Latest PTAB cases involving Inserm Institut National De La Sant Et De La Recherche Mdicale

Discover the latest PTAB cases involving Inserm Institut National De La Sant Et De La Recherche Mdicale, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Inserm Institut National De La Sant Et De La Recherche Mdicale with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE	-	35	-	-	Non-Active
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB	26	-	-	-	Highly Aggressive
SANOFI	59	23	-	-	Highly Aggressive
STRAWMAN	329	-	-	-	Highly Aggressive